Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Second Sight Medical Products, Inc. (EYES)

« Back to company index

EYES Chatter Timeline

Stock Ticker for EYES

Most Active Tweeters for EYES

UserTweets
@Marcouey 10
@TradeSmartStock 6
@BigBabuji 4
@PJ_Matlock 4
@WolfOfNorthAve 4

Recent Tweets for EYES

Davesnothere_ @Davesnothere_
$EYES gap from 3/4 is closed, lets see if we move up
May 23rd 2019, 7:05pm
Stock_News_Now @Stock_News_Now
$EYES: New SEC Filing for EYES: Form 8-K (No. 0001564590-19-020323): https://t.co/IYU6lU4L3Q
May 23rd 2019, 4:05pm
Marcouey @Marcouey
$EYES - Current Report Filing (8-k) https://t.co/Xi9EgH12fu
May 23rd 2019, 4:05pm
Davesnothere_ @Davesnothere_
addedsome to $EYES on this drop, .70
May 23rd 2019, 3:05pm
Stockdog101 @Stockdog101
Nostrildammus has $EYES CEO Jonathan Will Mcguire sold shares in the past? I noticed all of the buys, but he rec... https://t.co/Ds6G6ha6Av
May 23rd 2019, 3:05pm
76enz @76enz
$EYES
May 23rd 2019, 10:05am
TickerReport @TickerReport
Zacks Investment Research Lowers Second Sight Medical Products $EYES to Sell https://t.co/4vxernkq3V
May 23rd 2019, 5:05am
InsiderAlertsIA @InsiderAlertsIA
$EYES: New Insider Filing on Chief Executive Officer JONATHAN WILL MCGUIRE: https://t.co/yQyy36qilV
May 22nd 2019, 6:05pm
StockTexts @StockTexts
$EYES Second Sight Medical Products, Inc. SEC Filing: Form 4 https://t.co/M41bI7MPxU
May 22nd 2019, 6:05pm
TradeOnTheWire1 @TradeOnTheWire1
$EYES insider buy last night after huge eps run like r/w down here cheap bios been very hot and this one could go
May 22nd 2019, 1:05pm
76enz @76enz
$EYES https://t.co/cSBA5PfVVG
May 22nd 2019, 10:05am
InsiderAlertsIA @InsiderAlertsIA
$EYES: New Insider Filing on 10%+ Owner WILLIAMS GREGG: https://t.co/x65tyMqiLI
May 21st 2019, 7:05pm
StockTexts @StockTexts
$EYES Second Sight Medical Products, Inc. SEC Filing: Form 4 https://t.co/R8MosZYZlp
May 21st 2019, 6:05pm
Marcouey @Marcouey
$EYES - Statement of Changes in Beneficial Ownership (4) https://t.co/xIZXKHB6ZF
May 21st 2019, 6:05pm
ConsumerFeed @ConsumerFeed
Second Sight Medical Products $EYES Stock Rating Lowered by Zacks Investment Research https://t.co/iAT9YssjXh
May 18th 2019, 10:05am
TranscriptDaily @TranscriptDaily
Second Sight Medical Products $EYES Rating Lowered to Sell at ValuEngine https://t.co/3uNaGgUU1X
May 18th 2019, 9:05am
stocknewstimes @stocknewstimes
Second Sight Medical Products $EYES Rating Lowered to Sell at ValuEngine https://t.co/glMycd7QCN
May 18th 2019, 9:05am
SleekMoneycom @SleekMoneycom
Second Sight Medical Products $EYES Rating Lowered to Sell at ValuEngine https://t.co/aSdQoAgiwz #investing
May 18th 2019, 9:05am
TheMarketsDaily @TheMarketsDaily
Second Sight Medical Products $EYES Rating Lowered to Sell at ValuEngine https://t.co/M66JckGEdK
May 18th 2019, 9:05am
WatchlistN @WatchlistN
Second Sight Medical Products $EYES Shares Down 7.5% After Earnings Miss https://t.co/04XKYHYtjn
May 17th 2019, 10:05pm
InsiderAlertsIA @InsiderAlertsIA
$EYES: New Insider Filing on 10%+ Owner WILLIAMS GREGG: https://t.co/cAMsalUcsR
May 17th 2019, 9:05pm
StockTexts @StockTexts
$EYES Second Sight Medical Products, Inc. SEC Filing: Form 4 https://t.co/bl893Lugt6
May 17th 2019, 8:05pm
Stockdog101 @Stockdog101
@Will2ride @ForeverFree that is exactly what I’ve been doing and has worked great! $EYES
May 17th 2019, 3:05pm
macondailynews @macondailynews
Second Sight Medical Products $EYES Downgraded to “Sell” at ValuEngine https://t.co/NcxJfXinLZ
May 17th 2019, 11:05am
RockPaperMoon @RockPaperMoon
RT @MZ_NorthAmerica: Second Sight to Present at 20th Annual B. Riley FBR Investor Conference $EYES #medtech #sight https://t.co/9LUDZ8eL8d…
May 16th 2019, 5:05pm
MZ_NorthAmerica @MZ_NorthAmerica
Second Sight to Present at 20th Annual B. Riley FBR Investor Conference $EYES #medtech #sight… https://t.co/XI4EIedCbK
May 16th 2019, 5:05pm
ez_alertz @ez_alertz
$EYES Second Sight to Present at 20th Annual B. Riley FBR Investor Conference https://t.co/oBzWxbxmqL
May 16th 2019, 5:05pm
Marcouey @Marcouey
$EYES - Second Sight to Present at 20th Annual B. Riley FBR Investor Conference https://t.co/qmNkwWw8zO
May 16th 2019, 5:05pm
TheMarketsDaily @TheMarketsDaily
Second Sight Medical Products $EYES Announces Earnings Results, Misses Expectations By $0.04 EPS https://t.co/sDARTfc6wh
May 16th 2019, 11:05am
OpenOutcrier @OpenOutcrier
$EYES (+3.1% pre) Second Sight Medical (EYES) to Accelerate Development of Orion Visual Cortical Prosthesis System… https://t.co/VC0d5OWzoD
May 16th 2019, 8:05am
intercooleronli @intercooleronli
Second Sight Medical Products $EYES Lowered to “Sell” at ValuEngine https://t.co/dRxA4UAfP0 #investingnews
May 16th 2019, 3:05am
ledgerzette @ledgerzette
Second Sight Medical Products $EYES Lowered to “Sell” at ValuEngine https://t.co/WdLRElzE4n #stocks
May 16th 2019, 3:05am
fintel_io @fintel_io
$EYES / Second Sight Medical Products files form 8-K https://t.co/D68qduEdXz
May 16th 2019, 2:05am
fintel_io @fintel_io
$EYES / Second Sight Medical Products files form 10-Q https://t.co/hyx9XPyFzO
May 16th 2019, 2:05am
SiteFocusHQ @SiteFocusHQ
$EYES Qualitative Analysis of recent earnings identified Second Sight Medical Products (NASDAQ: EYES ) business foc… https://t.co/NByG1834UP
May 15th 2019, 11:05pm
NewsToDesk @NewsToDesk
$EYES: Second Sight Medical Products, Inc. (EYES) CEO Jonathan McGuire …: https://t.co/NQu4dRQYRj
May 15th 2019, 10:05pm
SeekingAlpha @SeekingAlpha
$EYES - Second Sight Medical Products, Inc. (EYES) CEO Jonathan McGuire on Q1 2019 Results - Earnings Call Transcri… https://t.co/9x8wfatpq0
May 15th 2019, 10:05pm
bulletin_en @bulletin_en
Allied Healthcare Products Inc. $EYES https://t.co/nfpVrNCljo
May 15th 2019, 8:05pm
StockNewsNow @StockNewsNow
$EYES Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System https://t.co/Uvu6j5h9NU
May 15th 2019, 6:05pm
StockNewsNow @StockNewsNow
$EYES Second Sight Reports First Quarter 2019 Financial Results https://t.co/9qknhF2oT4
May 15th 2019, 6:05pm
gordon_wolfe @gordon_wolfe
RT @7LadyQ: $EYES Second Sight: Encouraged by Talks With FDA on Regulatory Path and CMS on Reimbursement >EYES
May 15th 2019, 6:05pm
Marcouey @Marcouey
$EYES - Statement of Changes in Beneficial Ownership (4) https://t.co/beP8mguLjf
May 15th 2019, 5:05pm
Marcouey @Marcouey
$EYES - Current Report Filing (8-k) https://t.co/XdSAS3zLTx
May 15th 2019, 5:05pm
Johnstown12 @Johnstown12
@TradeSmartStock $EYES is running down the drain
May 15th 2019, 5:05pm
Marcouey @Marcouey
$EYES - Current Report Filing (8-k) https://t.co/swc9ep0TBQ
May 15th 2019, 4:05pm
Marcouey @Marcouey
$EYES - Quarterly Report (10-q) https://t.co/MN6fsIQ8h9
May 15th 2019, 4:05pm
Stock_News_Now @Stock_News_Now
$EYES: New SEC Filing for EYES: Form 10-Q (No. 0001564590-19-019432): https://t.co/J8jQycuV0Z
May 15th 2019, 4:05pm
newswithvalue @newswithvalue
$EYES: Second Sight up 14% on Q1 report, Orion outlook: https://t.co/lrVeHSX1jn
May 15th 2019, 4:05pm
NewsToDesk @NewsToDesk
$EYES: Second Sight Medical Products (EYES) Reports Q1 Loss, Misses Revenue Estimates: https://t.co/q5v4eAfAC4
May 15th 2019, 4:05pm
MarketCurrents @MarketCurrents
$EYES - Second Sight up 14% on Q1 report, Orion outlook https://t.co/qMjLoJ7voG
May 15th 2019, 4:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.